BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16373702)

  • 1. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
    Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
    Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.
    Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I
    J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified.
    Hoffmann JC; Chisholm KM; Cherry A; Chen J; Arber DA; Natkunam Y; Warnke RA; Ohgami RS
    Hum Pathol; 2016 Feb; 48():9-17. PubMed ID: 26772393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).
    Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N
    Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
    Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
    Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma.
    Smith TJ; Yamamoto K; Kurata M; Yukimori A; Suzuki S; Umeda S; Sugawara E; Kojima Y; Sawabe M; Nakagawa Y; Suzuki K; Crawley JT; Kitagawa M
    Exp Mol Pathol; 2010 Dec; 89(3):284-90. PubMed ID: 20800061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
    Cheng S; Zhang W; Inghirami G; Tam W
    Elife; 2021 Sep; 10():. PubMed ID: 34581268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
    Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
    Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of B-cell lymphoma cell lines with the t(14;18).
    Robetorye RS; Bohling SD; Morgan JW; Fillmore GC; Lim MS; Elenitoba-Johnson KS
    J Mol Diagn; 2002 Aug; 4(3):123-36. PubMed ID: 12169673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.
    Lee SS; Cho KJ; Kim CW; Kang YK
    Histopathology; 1999 Oct; 35(4):345-54. PubMed ID: 10564389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.
    Liggins AP; Cooper CD; Lawrie CH; Brown PJ; Collins GP; Hatton CS; Pulford K; Banham AH
    Br J Haematol; 2007 Aug; 138(4):479-86. PubMed ID: 17608765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
    Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
    Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of a composite lymphoma containing both T- and B-cell lymphomas.
    Suefuji N; Niino D; Arakawa F; Karube K; Kimura Y; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Ichikawa A; Sugita Y; Ohshima K
    Pathol Int; 2012 Oct; 62(10):690-8. PubMed ID: 23005596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of human lymphoid malignancies revealed by gene expression profiling.
    Staudt LM; Dave S
    Adv Immunol; 2005; 87():163-208. PubMed ID: 16102574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.
    Tam W; Gomez M; Chadburn A; Lee JW; Chan WC; Knowles DM
    Blood; 2006 May; 107(10):4090-100. PubMed ID: 16424392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
    Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
    Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.